One of our most common enemies is cancer. Everyone has experienced it either for themselves, through friends, or through loved ones. Thanks to Eric Lefkofsky some of the latest technology is making a heroic, grand entrance into this battle zone. Lefkofsky, co-founder of the popular discount shopping site, Groupon, has teamed up with Tempus to usher us in to the new age of data-enabled precision medicine.
The Tempus platform supports a software designed to integrate clinical records, and molecular(genome sequence)data. Human Genome Sequencing is believed to hold a multi-dimensional information bank containing data that is detrimental to effectively treating, preventing or curing cancers and similar diseases.
Though, still in a growth phase, the concept of data-enabled precision medicine is to determine highly specific treatments and medications tailored ‘precisely’ to the individual; Eventually, to aid in determining effective, precision treatments before trial or error.
When we look at Business Information systems today, we notice they are streamlined so that processes are literally, clicks in the cloud. Just think how many lives would be affected if this efficiency were applied to medical processing and analysis.
Currently medical information systems are past due for upgrades. As Liz, Eric’s wife, fought breast cancer, he saw this and realized how important efficient technologies can be during our lives greatest battles.
Data-enabled precision medicine is not Lefkofsky’s only project these days.
He and wife Liz regularly promote cancer research through their Lofkofsky Family Foundation, and have donated millions towards for cancer research projects.
The best use of technology would be promoting life. As CEO, and co-founder of Tempus, Eric is leading a movement that will introduce significant upgrades, as well as steady growth to medical technology and the future of medicine. There is no better way to promote life than to continuously open doors and facilitate progress.
Read More: adrinkwith.com/eric-lefkofsky/